Skip to Main content Skip to Navigation
Poster communications

Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.

Document type :
Poster communications
Complete list of metadata

https://hal.univ-brest.fr/hal-02151122
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Friday, June 7, 2019 - 4:59:02 PM
Last modification on : Wednesday, October 27, 2021 - 11:19:38 AM

Identifiers

  • HAL Id : hal-02151122, version 1

Collections

`

Citation

Alain Saraux, Thomas Barnetche, Guy Baudens, Isabelle Idier, Flore Delaporte, et al.. Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02151122⟩

Share

Metrics

Record views

41